Endocrinology Flashcards
Autoimmune destruction of the pancreatic beta cells, which will result in insulin dependence. Pts usually diagnosed in adolescence
Type I diabetes
Classically, DKA is seen with Type _ diabetes more often
type 1
Characterized by insulin resistance related to obesity. May occur at any age.
Type 2
Main distinction between type 1 and type 2 diabetes is that type 2 will not have:
Antibodies
Risk Factors for Type 2 Diabetes:
- > 45 y/o
- BMI . 25
- Diabetes mellitus in 1st degree relative
- Sedentary lifestyle
- Gestational DM
- Hx of delivery of child > 9 lbs
- Dyslipidemia
- HTN
- PCOS
Signs/Symptoms of diabetes
Polyuria, polydipsia, fatigue
More likely to present with a thin pt who is losing weight
Type 1 diabetes
More likely to present with obesity and acanthosis nigricans
Type 2 diabetes
Screening for diabetes
Screening should be done as part of cardiovascular risk assessment in adults aged 40-70 y/o with BMI > 25 years every 3 years
Screening Options for diabetes
- Two fasting glucose levels > 126
- One glucose level > 200 with symptoms
- HgA1c > 6.5%
- Positive 2 hour oral glucose tolerance test
Diagnosis for type 1 diabetes specifically
Positive antibodies
Low c-peptide, low insulin, elevated glucose
Diagnosis for type 2 diabetes specifically
No antibodies
Normal to increased c-peptide, normal to increased insulin, elevated glucose
Management of diabetes
HgA1c is drawn every 3-6 mo to evaluate management.
Goal HgA1c < 7%
May be drawn every 3 mo if not controlled, every 6 mo if well controlled
Treatment for Type 1 Diabetes
Insulin is mainstay. Should receive basal insulin (glargine or detemir) followed by pre-meal insulin
Four types of insulin
Rapid Acting
Fast Acting
Intermediate
Long Acting
Treatment for Type 2 Diabetes
Counseling on weight loss, exercise, and proper nutrition
First line - metformin
Second line - Sulfonylureas (glipizide, glimepiride)
If a pt has starting HgA1c > 9%
Want to start with insulin
Diabetes medications that cause weight gain and hypoglycemia
Insulin and sulfonylureas
Other second line options for diabetes (type 2)
- Pioglitazone
- DPP-4 Inhibitors
- Meglitinides
- GLP-1 agonists
5- Alpha-glucosidase inhibitors - SGLT2 inhibitors
Diabetic follow up care:
- Yearly eye exam to screen for retinopathy
- Yearly microalbumin screening
- Yearly comprehensive foot exam
Diabetic with LDL > 100
Statin first line
Diabetic with BP > 140/90
ACE/ARB first line
Adrenal insufficiency secondary to autoimmune destruction
Addison’s disease
Fatigue, weakness, anorexia, nausea, weight loss, hyperpigmentation
Addison’s disease